Identifying clinical predictors of response to repetitive transcranial magnetic stimulation for smoking cessation: Secondary analysis of a multicenter RCT.
- Resource Type
- Editorial & Opinion
- Authors
- Tang VM; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute for Medical Science, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Electronic address: Victor.Tang@camh.ca.; Zawertailo L; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Selby P; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute for Medical Science, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Zangen A; Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Zlotowski Centre for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Mehta D; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute for Medical Science, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada.; George TP; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute for Medical Science, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada.; Le Foll B; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute for Medical Science, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada.; Gicas KM; Department of Psychology, University of the Fraser Valley, Abbotsford, British Columbia, Canada.; Sloan ME; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute for Medical Science, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Temerty Faculty of Medicine, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Veldhuizen S; Institute of Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Source
- Publisher: Elsevier Country of Publication: United States NLM ID: 101465726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-4754 (Electronic) Linking ISSN: 18764754 NLM ISO Abbreviation: Brain Stimul Subsets: MEDLINE
- Subject
- Language
- English
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. B. Le Foll has been provided a coil for a Transcranial magnetic stimulation (TMS) study from Brainsway. Dr. A. Zangen is an inventor of deep TMS coils and has financial interest in BrainsWay which produces and markets these coils.